Join Growin Stock Community!

安美得7575.TW Overview

TW StockBiotech. & Medical
(No presentation for 7575)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

安美得(7575)Overall Performance

安美得(7575)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

安美得(7575) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

安美得(7575)Key Information

安美得(7575)Profile

Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan. It offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems that provides 24-hour oxygen supply to wounds under the Genadyne brand name; and wound treatment systems under the Natrox brand name. The company also provides 7-day long-acting pain reliever injections under the Naldebain brand name. In addition, it offers pressure injectable implantable port kits under the POLYSITE brand; and universal linear cutting staplers under the easyEndo brand name. The company was founded in 2008 and is based in New Taipei City, Taiwan.

安美得(7575)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
3.93
PE Ratio (TTM)
6.63
Forward PE
-
PS Ratio (TTM)
0.48
PB Ratio
2.12
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
67.33%
Net Margin
7.24%
Revenue Growth (YoY)
21.42%
Profit Growth (YoY)
13.82%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
3.93
PE Ratio (TTM)
6.63
Forward PE
-
PS Ratio (TTM)
0.48
PB Ratio
2.12
Price-to-FCF
-
Gross Margin
67.33%
Net Margin
7.24%
Revenue Growth (YoY)
21.42%
Profit Growth (YoY)
13.82%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
  • When is 7575's latest earnings report released?

    The most recent financial report for 安美得 (7575) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 7575's short-term business performance and financial health. For the latest updates on 7575's earnings releases, visit this page regularly.

  • Where does 7575 fall in the P/E River chart?

    According to historical valuation range analysis, 安美得 (7575)'s current price-to-earnings (P/E) ratio is 18.96, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 7575?

    According to the latest financial report, 安美得 (7575) reported an Operating Profit of 31M with an Operating Margin of 7.72% this period, representing a decline of 43.4% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 7575's revenue growth?

    In the latest financial report, 安美得 (7575) announced revenue of 401.51M, with a Year-Over-Year growth rate of 3.12%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 7575 have?

    At the end of the period, 安美得 (7575) held Total Cash and Cash Equivalents of 103.81M, accounting for 0.09 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 7575 go with three margins increasing?

    In the latest report, 安美得 (7575) achieved the “three margins increasing” benchmark, with a gross margin of 66.32%%, operating margin of 7.72%%, and net margin of 1.7%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 7575's profit trajectory and future growth potential.

  • Is 7575's EPS continuing to grow?

    According to the past four quarterly reports, 安美得 (7575)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.23. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 7575?

    安美得 (7575)'s Free Cash Flow (FCF) for the period is 62.22M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 97.19% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

default symbol

7575

安美得

26.05D

-4.61%

(-0.05)